Dr Anna Lydon

Dr Anna Lydon is a distinguished Consultant Clinical Oncologist dedicated to providing high-quality, patient-centred care for individuals undergoing cancer treatment. Specialising in non-surgical oncology, she focuses primarily on the diagnosis, management, and treatment of urological cancers, with a particular interest in prostate cancer. Dr Lydon is committed to improving patient outcomes through personalised treatment plans and the application of modern therapeutic techniques.

Her clinical practice encompasses advanced radiotherapy techniques, including stereotactic ablative radiotherapy (SABR) and high-dose rate brachytherapy, alongside systemic anti-cancer treatments. Dr Lydon has been heavily involved in clinical research, serving as a Chief Investigator and Principal Investigator for clinical trials focused on reducing treatment side effects, improving patient quality of life, and advancing multi-cancer early detection methods.

Dr Lydon completed higher specialist training in Clinical Oncology in the United Kingdom. She maintains full entry on the Specialist Register and is a Fellow of the Royal College of Radiologists. Alongside her clinical duties, she actively participates in clinical governance, multidisciplinary audit, and the educational supervision of medical students and oncology trainees.

Dedicated to reassuring her patients throughout their treatment journey, Dr Lydon prioritises open communication and compassionate guidance. Working closely within multidisciplinary cancer care teams, she ensures every patient receives tailored care designed to optimise clinical results while supporting their overall well-being.